Grail seeks €33m in compensation from EU over Illumina deal
( May 26, 2026, 08:38 GMT | Official Statement) -- MLex Summary: US biotech company Grail wants EU judges to award it €33 million plus interest in compensation over the European Commission's illegal intervention in a transaction with Illumina, according to pleas published in the Official Journal. In a lawsuit filed on April 1, Grail argues that the commission's move to assert jurisdiction over the deal caused it “actual and certain damage.”The excerpt from the Official Journal is attached. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.